Literature DB >> 25441491

Osteonecrosis in systemic lupus erythematosus.

Romina Patricia Gontero1, María Eugenia Bedoya1, Emilio Benavente1, Susana Graciela Roverano1, Sergio Oscar Paira2.   

Abstract

OBJECTIVES: To define the proportion of osteonecrosis (ON) in our patient population with lupus and to identify factors associated with the development of ON in systemic lupus erythematosus, as well as to carry out a descriptive analysis of ON cases.
MATERIALS AND METHODS: Observational retrospective study of 158 patients with SLE (ACR 1982 criteria). Demographic and laboratory data, clinical manifestations, SLICC, SLEDAI, cytotoxic and steroid treatments were compared. In patients with ON, we analyzed time of disease progression and age at ON diagnosis, form of presentation, joints involved, diagnostic methods, Ficat-Arlet classification, and treatment. To compare the means, t-test or Mann-Whitney's test were employed and the cHi-2 test or Fisher's exact test, as appropriate, were used to measure the equality of proportions.
RESULTS: ON was present in 15 out 158 patients (9.5%), 13 women and 2 men, with a mean age of 30 (r: 16-66) at diagnosis and 35 months of evolution until diagnosis (r: 1-195). Among the 15 patients, 34 joints presented ON, 23 were symptomatic and 22 were diagnosed by magnetic resonance images. Twenty-six occurred in hips (24 bilateral), 4 in knees and 4 in shoulders. In 13 patients, ON involved 2 or more joints. At onset, 28 joints were in stage i-ii, one in stage iii and 5 had no data and; in the end, 14 were in stage iii-iv, 5 in stage i-ii and 15 had no data. Twenty-nine underwent conservative treatment with rest and 8 hips required joint replacement. ON progression was associated with Cushing's syndrome (P=0.014) OR 4.16 (95% CI 1.4-12.6) and 2nd year SLICC (P=0.042). No relation with clinical manifestations, lab results, cytotoxic treatment, steroid treatment (total accumulated dose, mean daily dose and duration) metilprednisolone pulses, nor activity was found. All patients with ON received antimalarials, in contrast to 77% of those without ON.
CONCLUSIONS: The proportion of ON was 9.5%, mainly in women, 76% in hips (26) and 92% bilaterally. They were associated significantly with Cushing's syndrome and accumulated damage at second year.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Esteroides; Lupus eritematoso sistémico; Osteonecrosis; Steroids; Systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 25441491     DOI: 10.1016/j.reuma.2014.05.005

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  8 in total

1.  Clinical profile of osteonecrosis in systemic lupus erythematosus - Experience from a tertiary care centre in South India.

Authors:  Saranya Chinnadurai; Balaji Chilukuri; Bhuvanesh Mahendran; Vignesh Mantharam; Balameena Selvakumar; Rajeswari Sankaralingam
Journal:  J Family Med Prim Care       Date:  2020-08-25

2.  Circulating exosome levels in the diagnosis of steroid-induced osteonecrosis of the femoral head.

Authors:  H-Y Zhu; Y-C Gao; Y Wang; C-Q Zhang
Journal:  Bone Joint Res       Date:  2016-06       Impact factor: 5.853

3.  Urinary miRNAs as biomarkers for idiopathic osteonecrosis of femoral head: A multicentre study.

Authors:  Yongheng Ye; Yue Peng; Peiheng He; Qinqin Zhang; Dongliang Xu
Journal:  J Orthop Translat       Date:  2020-02-21       Impact factor: 5.191

4.  Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study.

Authors:  Shengbao Chen; Qianying Cai; Yanjun Xu; Qiong Fu; Yong Feng; Xiaoxiang Chen; Shengming Dai; Dongbao Zhao; Ce Zhan; Weidong Xu; Jiwei Wang; Yang Wang; Jinming Yu; Chunde Bao; Changqing Zhang
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-03-29       Impact factor: 5.346

Review 5.  Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients.

Authors:  Kaichi Kaneko; Hao Chen; Matthew Kaufman; Isaak Sverdlov; Emily M Stein; Kyung-Hyun Park-Min
Journal:  Clin Transl Med       Date:  2021-10

6.  Anti-RNP Antibody: A Potential Novel Predictor for Osteonecrosis in Systemic Lupus Erythematosus.

Authors:  Jiangbiao Xiong; Gang Wang; Tian Xu; Ren Liu; Shujiao Yu; Yan Wang; Rui Wu
Journal:  Front Med (Lausanne)       Date:  2022-04-11

7.  Clinical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction.

Authors:  Gui-Qi Zhu; Hong-Xia Qiu; Xin-Mei Ma; Mei-Xia Liu
Journal:  Int J Clin Pract       Date:  2022-07-18       Impact factor: 3.149

8.  A case of systemic lupus erythematosus presenting as bilateral avascular necrosis of femur.

Authors:  Madura Adikari; Aloka Gunawardane; Sachithra Illangantilaka; Himantha Atukorale; Jeevanie Rubasinghe
Journal:  BMC Res Notes       Date:  2016-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.